| 摘要 |
The present invention discloses the use of [R]-3-(2-deoxy- beta -D-erythropentofuranosyl)-3,6,7,8-tetrahydroimidazo-[4,5-d][1,3]diazepin-8-ol, also commonly known as pentostatin, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprised of such compounds, in the prophylactic or affirmative treatment of cerebral and cardiovascular disorders such as cerebral and myocardial ischemia. The invention also discloses the administration of pentostatin along with adenosine in the prophylactic or affirmative treatment of cerebral and cardiovascular disorders.
|
